PRESS RELEASE published on 10/21/2025 at 18:49, 1 month 14 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma annonce une validation historique dans la revue NATURE confirmant la causalité génétique de l'apolipoprotéine A-I (ApoA-I) dans le sepsis. Une avancée majeure dans le traitement de la septicémie Validation Historique ABIONYX Pharma Nature Septicémie Causalité Génétique
BRIEF published on 10/06/2025 at 15:00, 1 month 29 days ago Franchissement de seuil par la Caisse des dépôts et consignations dans ABIONYX PHARMA Droits De Vote Franchissement De Seuil CDC Bpifrance ABIONYX
BRIEF published on 10/06/2025 at 15:00, 1 month 29 days ago Threshold crossing by the Caisse des dépôts et consignations in ABIONYX PHARMA Voting Rights CDC Threshold Crossing Bpifrance ABIONYX
BRIEF published on 10/06/2025 at 14:56, 1 month 29 days ago Threshold Crossing by Bpifrance at ABIONYX PHARMA Voting Rights Actions Threshold Crossing Bpifrance ABIONYX Pharma
BRIEF published on 10/06/2025 at 14:56, 1 month 29 days ago Franchissement de Seuil par Bpifrance chez ABIONYX PHARMA Droits De Vote Franchissement De Seuil Actions Bpifrance ABIONYX Pharma
PRESS RELEASE published on 10/06/2025 at 14:55, 1 month 29 days ago Franchissement de seuil Déclaration de franchissement de seuil pour ABIONYX PHARMA par la Caisse des dépôts et consignations via Bpifrance Participations Déclaration Franchissement De Seuil Bpifrance Caisse Des Dépôts ABIONYX Pharma
PRESS RELEASE published on 10/06/2025 at 14:51, 1 month 29 days ago Franchissement de seuil Déclaration de franchissement de seuil par Bpifrance concernant ABIONYX PHARMA sur Euronext Paris, le 29 septembre 2025 Euronext Paris Franchissement De Seuil Bpifrance ABIONYX Pharma 29 Septembre 2025
BRIEF published on 09/25/2025 at 20:21, 2 months 9 days ago ABIONYX Pharma : Résultats financiers du premier semestre 2025 Résultats Financiers Recherche Et Développement Trésorerie Plan France 2030 ABIONYX Pharma
BRIEF published on 09/25/2025 at 20:21, 2 months 9 days ago ABIONYX Pharma: Financial results for the first half of 2025 Financial Results Research And Development Treasury France 2030 Plan ABIONYX Pharma
PRESS RELEASE published on 09/25/2025 at 20:16, 2 months 9 days ago Inside Information / News release on accounts, results ABIONYX Pharma announces its 2025 half-year financial results, including revenue of €2.1 million and ongoing initiatives in biotech innovation. Company receives government support for sepsis research Revenue Biotech Innovation ABIONYX Pharma 2025 Financial Results Sepsis Research
Published on 12/05/2025 at 02:35, 6 hours 37 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 8 hours 12 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 7 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 12 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:05, 7 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 27 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 27 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 30 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 14 hours 57 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 15 hours 12 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
